Evidence map›Paper›PMID 33257766›Full record

ArticleScientific reports2020

Identification of distinct immune activation profiles in adult humans.

Renaud Cezar, Audrey Winter, Delphine Desigaud, Manuela Pastore, Lucy Kundura, Anne-Marie Dupuy, Chantal Cognot, Thierry Vincent, Christelle Reynes, Catherine Dunyach-Remy and 5 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03309761 (Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03309761 completednot on this map

Description of an Immune Activation Profile Linked to Insulin Resistance in Subjects Aged 55-69

TypeobservationalSponsorCentre Hospitalier Universitaire de NīmesRan2017 to 2018Enrolled158ConditionsInsulin Resistance, Metabolic Syndrome XArmsBlood test
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Renaud CezarImmunology Department, Nîmes University Hospital, Place du Pr Debré, 30029, Nîmes, France.
Audrey WinterInstitute of Human Genetics, CNRS-Montpellier University UMR9002, 141 rue de la Cardonille, 34396, Montpellier Cedex 5, France.
Delphine DesigaudInstitute of Human Genetics, CNRS-Montpellier University UMR9002, 141 rue de la Cardonille, 34396, Montpellier Cedex 5, France.
Manuela PastoreInstitute of Functional Genomics UMR5203 and BCM, CNRS-INSERM-Montpellier University, 141 rue de la Cardonille, 34396, Montpellier, France.
Lucy KunduraInstitute of Human Genetics, CNRS-Montpellier University UMR9002, 141 rue de la Cardonille, 34396, Montpellier Cedex 5, France.
Anne-Marie DupuyBiochemestry Department, Montpellier University Hospital, 371 Avenue du Doyen Gaston Giraud, 34295, Montpellier, France.
Chantal CognotImmunology Department, Montpellier University Hospital, 80 Avenue Auguste Fliche, 34295, Montpellier, France.
Thierry VincentImmunology Department, Montpellier University Hospital, 80 Avenue Auguste Fliche, 34295, Montpellier, France.
Christelle ReynesInstitute of Functional Genomics UMR5203 and BCM, CNRS-INSERM-Montpellier University, 141 rue de la Cardonille, 34396, Montpellier, France.
Catherine Dunyach-RemyU1047, INSERM, Microbiology, Nîmes University Hospital, Montpellier University, Place du Pr Debré, 30029, Nîmes, France.
Jean-Philippe LavigneU1047, INSERM, Microbiology, Nîmes University Hospital, Montpellier University, Place du Pr Debré, 30029, Nîmes, France.
Robert SabatierInstitute of Functional Genomics UMR5203 and BCM, CNRS-INSERM-Montpellier University, 141 rue de la Cardonille, 34396, Montpellier, France.
Patricia Le MerreCaisse Primaire d'Assurance Maladie, 14 rue du Cirque Romain, Nîmes, France.
Elisabeth MaggiaCaisse Primaire d'Assurance Maladie, 14 rue du Cirque Romain, Nîmes, France.
Pierre CorbeauImmunology Department, Nîmes University Hospital, Place du Pr Debré, 30029, Nîmes, France. pcorbeau@igh.cnrs.fr.
Université de Montpellier · FRInstitut de Génétique Humaine · FRInstitut de Génomique Fonctionnelle · FRl'Assurance Maladie · FRBacterial Virulence and Chronic InfectionsCentre National de la Recherche Scientifique · FRInstitute for Neurosciences of Montpellier · FRNeuropsychiatrie : Recherche Epidemiologique et Clinique · FRUniversité de Nîmes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latent infectious agents, microbial translocation, some metabolites and immune cell subpopulations, as well as senescence modulate the level and quality of activation of our immune system. Here, we tested whether various in vivo immune activation profiles may be distinguished in a general population. We measured 43 markers of immune activation by 8-color flow cytometry and ELISA in 150 adults, and performed a double hierarchical clustering of biomarkers and volunteers. We identified five different immune activation profiles. Profile 1 had a high proportion of naïve T cells. By contrast, Profiles 2 and 3 had an elevated percentage of terminally differentiated and of senescent CD4+ T cells and CD8+ T cells, respectively. The fourth profile was characterized by NK cell activation, and the last profile, Profile 5, by a high proportion of monocytes. In search for etiologic factors that could determine these profiles, we observed a high frequency of naïve Treg cells in Profile 1, contrasting with a tendency to a low percentage of Treg cells in Profiles 2 and 3. Moreover, Profile 5 tended to have a high level of 16s ribosomal DNA, a direct marker of microbial translocation. These data are compatible with a model in which specific causes, as the frequency of Treg or the level of microbial translocation, shape specific profiles of immune activation. It will be of interest to analyze whether some of these profiles drive preferentially some morbidities known to be fueled by immune activation, as insulin resistance, atherothrombosis or liver steatosis.

Indexed as

AgedBiological Variation, PopulationFemaleHumansImmunity, CellularKiller Cells, NaturalMaleMiddle AgedModels, ImmunologicalMonocytesT-LymphocytesT-Lymphocytes, Regulatory

Identifiers

PMID33257766
PMCPMC7704615
OpenAlexW3109260444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.